These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34930134)

  • 1. Plasma atherogenic indices are independent predictors of slow coronary flow.
    Afsin A; Kaya H; Suner A; Uzel KE; Bursa N; Hosoglu Y; Yavuz F; Asoglu R
    BMC Cardiovasc Disord; 2021 Dec; 21(1):608. PubMed ID: 34930134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Atherogenic Index of Plasma on Pre-Percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow in Patients With ST Elevation Myocardial Infarction.
    Aydınyılmaz F; Özbeyaz NB; Guliyev İ; Algül E; Şahan HF; Kalkan K
    Angiology; 2024 Oct; 75(9):841-848. PubMed ID: 37399526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Süleymanoğlu M; Rencüzoğulları İ; Karabağ Y; Çağdaş M; Yesin M; Gümüşdağ A; Çap M; Gök M; Yıldız İ
    Int J Cardiovasc Imaging; 2020 May; 36(5):789-796. PubMed ID: 31919706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
    Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
    BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of syntax score and syntax score II to predict "no reflow phenomenon" in patients with ST-segment elevation myocardial infarction.
    Yesin M; Çağdaş M; Kalçık M; Uluganyan M; Efe SÇ; Rencüzoğulları İ; Karabağ Y; Gürsoy MO; Karakoyun S
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1883-1889. PubMed ID: 28664479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.
    Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
    Clin Cardiol; 2010 Dec; 33(12):E7-12. PubMed ID: 21184547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation value of atherogenic index of plasma and high-sensitivity C-reactive protein for the degree of coronary artery lesion in premature coronary artery disease.
    Song Y; Wang M; Li Y; Lian Y
    BMC Cardiovasc Disord; 2024 Aug; 24(1):410. PubMed ID: 39107719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid to albumin ratio as a novel predictor for coronary slow flow phenomenon in patients with chronic coronary syndrome and non-obstructive coronary arteries.
    Zhang XJ; Hou AJ; Luan B; Wang CF; Li JJ
    BMC Cardiovasc Disord; 2024 Jul; 24(1):358. PubMed ID: 39003493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study.
    Mukhopadhyay S; Kumar M; Yusuf J; Gupta VK; Tyagi S
    Indian Heart J; 2018; 70(3):405-409. PubMed ID: 29961458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia.
    Yang Z; Yuan J; Cui J; Guan H; Qiao S
    BMC Cardiovasc Disord; 2021 Mar; 21(1):156. PubMed ID: 33781230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and clinical outcomes of slow flow phenomenon in diabetic patients with chronic coronary syndrome.
    Khalil MA; Khalfallah M; Elsheikh A
    BMC Cardiovasc Disord; 2024 Sep; 24(1):518. PubMed ID: 39333842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profile and atherogenic indices in patients with stable chronic obstructive pulmonary disease.
    Markelić I; Hlapčić I; Rogić D; Rako I; Samaržija M; Popović-Grle S; Rumora L; Vukić Dugac A
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):153-161. PubMed ID: 32981798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Refaat H; Tantawy A; Gamal AS; Radwan H
    Indian Heart J; 2021; 73(1):35-43. PubMed ID: 33714407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.
    Zengin H; Erbay AR; Okuyucu A; Alaçam H; Yüksel S; Meriç M; Soylu K; Gedikli Ö; Murat N; Gülel O; Demircan S; Akın F; Yılmaz Ö; Şahin M
    Anatol J Cardiol; 2015 Jun; 15(6):475-9. PubMed ID: 25430414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of plaque components analyzed by integrated backscatter intravascular ultrasound and serum pregnancy-associated plasma protein a levels predict the no-reflow phenomenon during percutaneous coronary intervention.
    Daidoji H; Takahashi H; Otaki Y; Tamura H; Arimoto T; Shishido T; Miyashita T; Miyamoto T; Watanabe T; Kubota I
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):43-50. PubMed ID: 24227626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serum salusin beta levels with coronary slow flow.
    Akyüz A; Aydın F; Alpsoy Ş; Ozkaramanli Gur D; Guzel S
    Anatol J Cardiol; 2019 Sep; 22(4):177-184. PubMed ID: 31584433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between plasma miR-126 and coronary slow flow phenomenon].
    Wang L; Wang HN; Zu XL
    Zhonghua Yi Xue Za Zhi; 2019 May; 99(17):1323-1327. PubMed ID: 31091580
    [No Abstract]   [Full Text] [Related]  

  • 20. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis.
    Rabiee Rad M; Ghasempour Dabaghi G; Darouei B; Amani-Beni R
    Cardiovasc Diabetol; 2024 Apr; 23(1):119. PubMed ID: 38566139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.